XOMOLIX

This brand name is authorized in Austria, Spain, Ireland, United Kingdom

Active ingredients

The drug XOMOLIX contains one active pharmaceutical ingredient (API):

1 Droperidol
UNII O9U0F09D5X - DROPERIDOL

Droperidol is a butyrophenone neuroleptic. Its pharmacologic profile is characterised mainly by dopamine-blocking and weak ฮฑ1-adrenolytic effects. Droperidol is devoid of anticholinergic and antihistaminic activity.

Read about Droperidol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
XOMOLIX Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AD08 Droperidol N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AD Butyrophenone derivatives
Discover more medicines within N05AD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 69837
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 154327

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈